163 related articles for article (PubMed ID: 35816999)
21. Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are.
Rossi RE; Elvevi A; Gallo C; Palermo A; Invernizzi P; Massironi S
World J Gastroenterol; 2022 Jul; 28(26):3258-3273. PubMed ID: 36051341
[TBL] [Abstract][Full Text] [Related]
22. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors.
Partelli S; Maurizi A; Tamburrino D; Baldoni A; Polenta V; Crippa S; Falconi M
Eur J Endocrinol; 2014 Oct; 171(4):R153-62. PubMed ID: 24920289
[TBL] [Abstract][Full Text] [Related]
23. Imaging features of malignant abdominal neuroendocrine tumors with rare presentation.
Corrias G; Monti S; Horvat N; Tang L; Basturk O; Saba L; Mannelli L
Clin Imaging; 2018; 51():59-64. PubMed ID: 29448120
[TBL] [Abstract][Full Text] [Related]
24. Presentation and survival of gastro-entero-pancreatic neuroendocrine tumors in young adults versus older patients.
Nguyen AH; O'Leary MP; De Andrade JP; Ituarte PG; Warner SG; Melstrom LG; Kessler J; Fong Y; Li D; Singh G
Am J Surg; 2022 May; 223(5):939-944. PubMed ID: 34474917
[TBL] [Abstract][Full Text] [Related]
25. A case of positive
Zilli A; Fanetti I; Conte D; Massironi S
Clin Imaging; 2018; 49():156-158. PubMed ID: 29529451
[TBL] [Abstract][Full Text] [Related]
26. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
27. Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas.
Pavel ME; Hassler G; Baum U; Hahn EG; Lohmann T; Schuppan D
Clin Endocrinol (Oxf); 2005 Apr; 62(4):434-43. PubMed ID: 15807874
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Gastroenteropancreatic Neuroendocrine Tumors.
Perez K; Chan J
Surg Pathol Clin; 2019 Dec; 12(4):1045-1053. PubMed ID: 31672293
[TBL] [Abstract][Full Text] [Related]
29. Reassessing the grade of gastroenteropancreatic neuroendocrine neoplasms.
Klimstra DS
Endocrine; 2016 Jul; 53(1):4-6. PubMed ID: 27150611
[No Abstract] [Full Text] [Related]
30. Management of gastro-entero-pancreatic neuroendocrine tumours (GEP NET): an introduction.
Van Hootegem P; Borbath I; Verslype C
Acta Gastroenterol Belg; 2009; 72(1):27-8. PubMed ID: 19402367
[No Abstract] [Full Text] [Related]
31. Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management.
Panzuto F; Massironi S; Partelli S; Campana D; Rinzivillo M; Invernizzi P; Andreasi V; Lamberti G; Falconi M
Surg Oncol; 2020 Dec; 35():141-148. PubMed ID: 32877883
[TBL] [Abstract][Full Text] [Related]
32. A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma.
Arabadzhieva E; Yonkov A; Bonev S; Bulanov D; Taneva I; Vlahova A; Dikov T; Dimitrova V
World J Surg Oncol; 2016 Nov; 14(1):287. PubMed ID: 27846844
[TBL] [Abstract][Full Text] [Related]
33. Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.
Holmager P; Langer SW; Kjaer A; Ringholm L; Garbyal RS; Pommergaard HC; Hansen CP; Federspiel B; Andreassen M; Knigge U
Curr Treat Options Oncol; 2022 Jun; 23(6):806-817. PubMed ID: 35362798
[TBL] [Abstract][Full Text] [Related]
34. Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract.
Goretzki PE; Mogl MT; Akca A; Pratschke J
Rev Endocr Metab Disord; 2018 Jun; 19(2):169-178. PubMed ID: 30280290
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms.
Attili F; Capurso G; Vanella G; Fuccio L; Delle Fave G; Costamagna G; Larghi A
Dig Liver Dis; 2014 Jan; 46(1):9-17. PubMed ID: 23731843
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs and Treatment with Somatostatin Analogs in Gastro- Entero-Pancreatic Neuroendocrine Neoplasms: Challenges in Personalized Medicine.
Curt AM; Popa Ilie IR; Cainap C; Balacescu O; Ghervan C
J Gastrointestin Liver Dis; 2020 Dec; 29(4):647-659. PubMed ID: 33331339
[TBL] [Abstract][Full Text] [Related]
38. Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges.
Garcia-Carbonero R
Cancer Metastasis Rev; 2014 Mar; 33(1):343-4. PubMed ID: 24357057
[No Abstract] [Full Text] [Related]
39. Insurance-based Disparities in Gastro-Entero-Pancreatic Neuroendocrine Tumor Patients.
Baechle JJ; Smith PM; Idrees K
J Health Care Poor Underserved; 2021; 32(3):1199-1207. PubMed ID: 34421025
[TBL] [Abstract][Full Text] [Related]
40. [Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research].
Luley K; Gebauer J; Gebauer N; Tharun L; Buchmann I; Barkhausen J; von Bubnoff N; Lindner K; Keck T; Lehnert H; Schmid SM
Internist (Berl); 2020 Aug; 61(8):875-890. PubMed ID: 32676723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
